These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

970 related items for PubMed ID: 29105558

  • 21. Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis.
    Ong LM, Hooi LS, Lim TO, Goh BL, Ahmad G, Ghazalli R, Teo SM, Wong HS, Tan SY, Shaariah W, Tan CC, Morad Z.
    Nephrology (Carlton); 2005 Oct; 10(5):504-10. PubMed ID: 16221103
    [Abstract] [Full Text] [Related]

  • 22. Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial.
    Sedhain A, Hada R, Agrawal RK, Bhattarai GR, Baral A.
    BMC Nephrol; 2018 Jul 11; 19(1):175. PubMed ID: 29996800
    [Abstract] [Full Text] [Related]

  • 23. Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis.
    Mok CC, Ho LY, Ying SKY, Leung MC, To CH, Ng WL.
    Ann Rheum Dis; 2020 Aug 11; 79(8):1070-1076. PubMed ID: 32448782
    [Abstract] [Full Text] [Related]

  • 24. Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial.
    Ginzler EM, Wofsy D, Isenberg D, Gordon C, Lisk L, Dooley MA, ALMS Group.
    Arthritis Rheum; 2010 Jan 11; 62(1):211-21. PubMed ID: 20039429
    [Abstract] [Full Text] [Related]

  • 25. Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis: a randomised controlled trial.
    Nikolopoulou A, Condon M, Turner-Stokes T, Cook HT, Duncan N, Galliford JW, Levy JB, Lightstone L, Pusey CD, Roufosse C, Cairns TD, Griffith ME.
    BMC Nephrol; 2019 Sep 06; 20(1):352. PubMed ID: 31492152
    [Abstract] [Full Text] [Related]

  • 26. Mycophenolate mofetil or tacrolimus compared with azathioprine in long-term maintenance treatment for active lupus nephritis.
    Zhang Q, Xing P, Ren H, Chen X, Xie J, Zhang W, Shen P, Li X, Chen N.
    Front Med; 2022 Oct 06; 16(5):799-807. PubMed ID: 35305232
    [Abstract] [Full Text] [Related]

  • 27. A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis.
    F L, Y T, X P, L W, H W, Z S, H Z, Z H, MMF in Induction Therapy for Active Lupus Nephritis in Mainland China Study Group.
    Lupus; 2008 Jul 06; 17(7):622-9. PubMed ID: 18625634
    [Abstract] [Full Text] [Related]

  • 28. [Mycophenolate mofetil maintenance therapy in lupus nephritis].
    Milewski M, Jakieła B, Zółciński M, Chmielewska A, Musiał J.
    Pol Arch Med Wewn; 2006 Oct 06; 116(4):947-54. PubMed ID: 18416296
    [Abstract] [Full Text] [Related]

  • 29. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.
    Moroni G, Raffiotta F, Trezzi B, Giglio E, Mezzina N, Del Papa N, Meroni P, Messa P, Sinico AR.
    Rheumatology (Oxford); 2014 Sep 06; 53(9):1570-7. PubMed ID: 24505125
    [Abstract] [Full Text] [Related]

  • 30. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
    Sahin GM, Sahin S, Kiziltas S, Masatlioglu S, Oguz F, Ergin H.
    Ren Fail; 2008 Sep 06; 30(9):865-9. PubMed ID: 18925525
    [Abstract] [Full Text] [Related]

  • 31. Immunosuppressive therapies for the induction treatment of proliferative lupus nephritis: a systematic review and network metaanalysis.
    Tian SY, Feldman BM, Beyene J, Brown PE, Uleryk EM, Silverman ED.
    J Rheumatol; 2014 Oct 06; 41(10):1998-2007. PubMed ID: 25225281
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and safety of immunosuppressive agents for adults with lupus nephritis: a systematic review and network meta-analysis.
    Jiang N, Jin S, Yu C, Zhao J, Wang Q, Tian X, Li M, Zeng X.
    Front Immunol; 2023 Oct 06; 14():1232244. PubMed ID: 37901212
    [Abstract] [Full Text] [Related]

  • 33. Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis.
    Lanata CM, Mahmood T, Fine DM, Petri M.
    Lupus; 2010 Jul 06; 19(8):935-40. PubMed ID: 20388722
    [Abstract] [Full Text] [Related]

  • 34. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
    Zhu B, Chen N, Lin Y, Ren H, Zhang W, Wang W, Pan X, Yu H.
    Nephrol Dial Transplant; 2007 Jul 06; 22(7):1933-42. PubMed ID: 17405792
    [Abstract] [Full Text] [Related]

  • 35. Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.
    Mok CC.
    Nephrol Dial Transplant; 2016 Oct 06; 31(10):1561-6. PubMed ID: 27591327
    [Abstract] [Full Text] [Related]

  • 36. Retrospective analysis of nephritis response and renal outcome in a cohort of 928 Egyptian lupus nephritis patients: a university hospital experience.
    Momtaz M, Fayed A, Wadie M, Gamal SM, Ghoniem SA, Sobhy N, Kamal Elden NM, Hamza WM.
    Lupus; 2017 Dec 06; 26(14):1564-1570. PubMed ID: 28625079
    [Abstract] [Full Text] [Related]

  • 37. Steroid withdrawal at 3 months after kidney transplantation: a comparison of two tacrolimus-based regimens.
    Wlodarczyk Z, Walaszewski J, Perner F, Vitko S, Ostrowski M, Bachleda P, Kokot F, Klinger M, Szenohradszky P, Studenik P, Navratil P, Asztalos L, Rutkowski B, Kalmar KN, Hickey D.
    Transpl Int; 2005 Feb 06; 18(2):157-62. PubMed ID: 15691267
    [Abstract] [Full Text] [Related]

  • 38. Efficacy and safety of tacrolimus for induction therapy in patients with active lupus nephritis.
    Takahashi S, Hiromura K, Sakurai N, Matsumoto T, Ikeuchi H, Maeshima A, Kaneko Y, Kuroiwa T, Nojima Y.
    Mod Rheumatol; 2011 Jun 06; 21(3):282-9. PubMed ID: 21188448
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
    Wang J, Mao J, Chen J, Fu H, Shen H, Zhu X, Liu A, Shu Q, Du L.
    Nephrology (Carlton); 2016 Jan 06; 21(1):21-7. PubMed ID: 26697959
    [Abstract] [Full Text] [Related]

  • 40. Comparative efficacy and safety of tacrolimus, mycophenolate mofetil, azathioprine, and cyclophosphamide as maintenance therapy for lupus nephritis : A Bayesian network meta-analysis of randomized controlled trials.
    Lee YH, Song GG.
    Z Rheumatol; 2017 Dec 06; 76(10):904-912. PubMed ID: 27638015
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 49.